Skip to main navigation

Main Nav

About Us
Scientific Platform
Our Pipeline
Career Opportunities
Investors & Media

Press Releases

IR Nav

Overview
Press Releases
Events
Presentations
Annual Reports
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
FAQs
Email Alerts
Investor Contact

Shareholder Tools

Press Releases

Year

Gritstone Announces Promotions Within its Leadership Team

March 8, 2021

Gritstone to Present at the H.C. Wainwright Global Life Sciences Conference

March 2, 2021

Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstone’s Vaccine Platform Technology for HIV Cure

February 1, 2021

Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine

January 20, 2021

Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support from NIAID; Program has Potential to Protect Against Mutant Variants of SARS-CoV-2

January 19, 2021

Gritstone Oncology to Present at the 39th Annual J.P. Morgan Healthcare Conference

January 11, 2021

Gritstone Oncology Announces Private Placement Financings Totaling $125 Million

December 28, 2020

Gritstone Oncology Announces $110 Million Private Placement

December 23, 2020

Gritstone Oncology Reports Third Quarter Financial Results and Recent Highlights

November 5, 2020

Gritstone Oncology Advances into Phase 2 Expansion Cohorts for its Personalized Neoantigen Immunotherapy GRANITE and its Off-the-Shelf Neoantigen Immunotherapy SLATE

November 2, 2020

Pagination

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Page 11
…
Next page
Last page

© 2022 Gritstone Bio |

Footer Links

Privacy Policy
Terms of Use
Contact

socials

Top